There is no government data yet on whether health authorities’
10-day halt in administration of the Johnson & Johnson vaccine
soured people on the product, and the company declined to discuss
the matter. But in spot checks across the country, people seeking
vaccines and officials dispensing them appear eager to resume
using the vaccine, which is also easier to store and transport.
On Tuesday, for example, 1,355 people at the racetrack chose
Johnson & Johnson at the clinic run by Indiana University Health,
while 407 took the Pfizer vaccine, according to spokesman
Jonathon Hosea. At a homeless program in San Francisco,
drugstores in Maine and universities across the country, the same
sentiment is largely true.